Biological age vs. chronological age: which test should you actually get?

The three ways to estimate it, and what they actually cost

There is no single "biological age test." There are three different families of methods, built from different raw inputs, at wildly different price points. None of them measure age directly — they all infer it from a proxy that correlates with aging, which is worth keeping in mind before you trust any single number too far.

The cost gap is the whole story here: an epigenetic test is a single, relatively expensive snapshot; a wearable estimate is free and updates every day. That asymmetry should drive which one you actually reach for.

What moves the number, and how fast

Whichever method you use, the underlying levers are the same handful of things — they just get measured with different precision and different lag.

• Cardio fitness (VO2max) — the heaviest-weighted driver in most models. Meaningful movement takes months of consistent aerobic training, but it's worth the most when it moves.
• Resting heart rate and HRV — respond within weeks to consistent training, better sleep and less alcohol. See our guide on improving HRV for the ranked list of what actually works.
• Sleep quality and consistency — usually the fastest-moving lever; a few genuinely good weeks show up quickly in wearable-based estimates.
• Daily activity (steps, movement) — a steady contributor; going from sedentary to roughly 8,000 steps matters far more than going from 8,000 to 12,000.
• What doesn't move it — supplements or biohacks with no measurable effect on VO2max, resting heart rate, HRV, sleep or blood markers won't move any of these three estimate types, because none of them measure "the supplement" — they measure its downstream physiological effect, or lack of one.

Whether a lifestyle change shows up on a wearable estimate within a month and on an epigenetic clock within a year are two different claims — the wearable number is reactive because it's rebuilt from fresh data daily; methylation is a slower-moving biological signal, and most published studies tracking it use multi-year windows, not weeks.

A decision protocol: which test should you actually get

Match the method to what you're actually trying to learn, not to which one sounds most scientific.

1. You want to know if this month's training and sleep changes are working. Use a wearable-based estimate. It's free, it updates continuously, and "is my number trending down" is exactly the question it answers well.
2. You want a single credible number for curiosity, motivation, or a longevity-focused check-in once a year. A blood-biomarker score is the reasonable middle option — meaningfully cheaper than an epigenetic panel, and you may already have most of the underlying labs from a routine physical.
3. You want the closest thing to a research-grade estimate, or you're specifically interested in aging biology rather than day-to-day feedback. An epigenetic clock is the appropriate (and most expensive) choice — but expect to repeat it at most once a year to see meaningful change, not monthly.
4. You want to track a single number over time without paying repeatedly. This only works with the wearable-based family — it's the only one of the three built to be free and continuous by design.

Most people asking "should I get a biological age test" are actually asking question 1, and don't need to spend anything to answer it.

How much should you actually trust the number?

Be honest with yourself about what these estimates can and can't tell you.

• They're population-based, not personalized diagnoses. Every method compares your markers to reference ranges built from study populations — validation research for these estimators has skewed heavily toward specific ancestry groups, so accuracy for other populations is less well established. Treat any single number as an estimate with real uncertainty, not a lab-grade result.
• Direction matters more than the exact number. Whether your estimate is "38" or "42" in absolute terms is far less informative than whether it's been trending down for three months. All three methods are more trustworthy as a trend line than as a one-off figure.
• Different methods aren't interchangeable. A wearable estimate, a blood score and an epigenetic clock use different inputs and different reference populations, so they will legitimately disagree with each other. Comparing your WHOOP Age to your Body Age to a TruAge result and expecting them to match is comparing three different rulers.
• Correlation with outcomes isn't the same as certainty for you. Published research shows real correlation between these markers and long-term health outcomes at a population level — that's meaningfully more than a horoscope, but it's still a statistical relationship, not a personal prediction.

Wearable Body Age vs WHOOP Age — the practical difference

If you land on the wearable-based family (the right call for most people, per the protocol above), it's worth knowing that WHOOP's own Healthspan feature already estimates a WHOOP Age from WHOOP's sleep, strain and heart-rate data — it's a legitimate implementation of the same family of estimate. Vita's Body Age belongs to the same family with one structural difference: it fuses WHOOP data (when you have a band) with Apple Health (always) and lets markers from uploaded lab reports sit alongside the wearable data, so the estimate keeps working if you switch devices and reflects more of your actual physiology than any single source alone. Neither is a substitute for an epigenetic clock if that's specifically what you're after — but for the "is this working" question most people actually have, both are the right tool, and Vita's cross-source version is the more resilient one if your data source ever changes. See Vita vs. WHOOP for the fuller comparison.

The bottom line

Chronological age is a fact; biological age is an estimate — and which estimate you should pay for depends entirely on the question you're asking. For "is what I'm doing working," a free, continuous wearable-based number like Body Age answers it better than an annual $300 blood draw ever could, simply because it updates as often as your data does. For a once-a-year, research-adjacent check-in, a blood or epigenetic test is the more appropriate (and pricier) tool. Whichever you choose, judge it on its trend over months, not its value on any single day.